doi:10.1111/bcpt.13289 66
Approval for Cardiovascular Risk Reduction Ongoing cardiovascular outcomes trials (CVOT) studies clearly demonstrated that three of the diabetes incretin medications (liraglutide, dulaglutide and semaglutide) and one of the weight loss versions of this class (Wegovy) also reduce cardiovascular disease risk
You can ask for a prescription from your primary care provider, or you can sign up for a weight loss platform that helps facilitate conversations with healthcare providers, like Hers or Ro
At the same time, WeightWatchers layers in nutrition guidance focused on protein, hydration, and balanced meals to support healthy weight loss
Regulatory peptides 155, 121130, doi: 10.1016/j.regpep.2009.04.009 (2009)
For patients considering Independent Wellness, care is provider-led by Bonnie Lea Davis, FNP-C, with personalized GLP-1 plans, direct provider access, labs through Quest Diagnostics when appropriate, and medication shipped directly to your door if prescribed